US Stock MarketDetailed Quotes

RKDA Arcadia Biosciences

Watchlist
  • 3.590
  • +0.260+7.81%
Trading Apr 30 14:20 ET
4.91MMarket Cap-0.69P/E (TTM)

Arcadia Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
13.27%5.05M
56.50%1.22M
18.41%1.54M
0.69%1.31M
1.87%1.26M
-39.96%4.45M
4.44%777K
-17.32%1.3M
-66.38%1.3M
-61.74%1.23M
Operating revenue
13.27%5.05M
56.50%1.22M
18.41%1.54M
0.69%1.31M
1.87%1.26M
-39.96%4.45M
4.44%777K
-17.32%1.3M
-66.38%1.3M
-61.74%1.23M
Cost of revenue
36.29%2.96M
364.61%827K
26.16%1.03M
-2.62%633K
19.19%820K
-64.37%2.17M
-80.22%178K
-27.48%818K
-81.14%650K
-80.10%688K
Gross profit
-8.68%2.08M
-35.06%389K
5.21%505K
4.02%673K
-20.04%435K
73.12%2.28M
483.97%599K
8.60%480K
57.42%647K
328.57%544K
Operating expense
16.82%9.69M
56.21%2.67M
20.67%2.27M
28.18%2.69M
-21.87%3.46M
-49.85%8.3M
-58.63%1.71M
-57.66%1.88M
-58.07%2.1M
-6.62%4.43M
Selling and administrative expenses
17.09%9.64M
56.27%2.66M
20.35%2.24M
29.36%2.68M
-21.67%3.19M
-45.24%8.23M
-53.18%1.7M
-55.43%1.86M
-55.42%2.07M
-6.39%4.07M
Research and development costs
-17.19%53K
44.44%13K
60.00%24K
-62.96%10K
-24.23%272K
-95.76%64K
-98.20%9K
-94.12%15K
-92.48%27K
-9.11%359K
Operating profit
-26.49%-7.61M
-105.50%-2.28M
-25.98%-1.76M
-38.93%-2.02M
22.13%-3.03M
60.48%-6.02M
74.12%-1.11M
65.00%-1.4M
68.39%-1.45M
22.00%-3.89M
Net non-operating interest income expense
12.52%782K
125.48%354K
75.19%233K
-27.54%150K
-77.27%45K
140.48%695K
-5.42%157K
40.00%133K
590.00%207K
19,900.00%198K
Non-operating interest income
12.52%782K
125.48%354K
75.19%233K
-27.54%150K
-77.27%45K
140.48%695K
-5.42%157K
40.00%133K
590.00%207K
--198K
Other net income (expense)
125,950.00%2.52M
-514.99%-2.1M
-44.80%345K
-15.51%3.72M
110.12%558K
-99.95%2K
-46.74%507K
-61.16%625K
469.60%4.4M
-1,578.55%-5.52M
Gain on sale of security
-414.96%-1.47M
-439.72%-1.97M
-45.72%330K
-109.74%-430K
111.55%593K
-85.42%468K
-56.43%579K
-67.66%608K
--4.42M
---5.14M
Earnings from equity interest
----
----
----
----
--0
----
----
----
----
---430K
Special income (charges)
4,819.05%3.96M
--0
--0
--4M
-300.00%-38K
-106.88%-84K
77.48%-84K
--0
--0
-94.71%19K
-Less:Impairment of capital assets
-68.14%36K
--0
--0
--0
--36K
-62.46%113K
--113K
--0
--0
--0
-Gain on sale of property,plant,equipment
13,693.10%4M
--0
--0
--4M
-110.53%-2K
-90.76%29K
140.28%29K
--0
--0
-94.21%19K
Other non- operating income (expenses)
108.12%31K
-1,241.67%-137K
-11.76%15K
1,253.85%150K
-90.63%3K
-25.25%-382K
400.00%12K
106.27%17K
70.45%-13K
128.57%32K
Income before tax
19.02%-4.31M
-805.39%-4.03M
-84.98%-1.18M
-41.38%1.85M
73.67%-2.42M
50.80%-5.32M
85.95%-445K
72.06%-639K
183.12%3.16M
-99.63%-9.2M
Income tax
0.00%8K
14.29%8K
0
0
-42.86%8K
-46.15%7K
0
1K
Net income
49.68%-7.04M
-42.45%-4.06M
37.20%-1.61M
29.71%1.06M
74.18%-2.42M
10.42%-13.99M
34.08%-2.85M
10.78%-2.57M
121.54%818K
-103.56%-9.38M
Net income continuous Operations
18.99%-4.32M
-793.14%-4.04M
-84.98%-1.18M
-41.36%1.85M
73.67%-2.42M
50.79%-5.33M
85.79%-452K
72.07%-639K
183.09%3.16M
-99.63%-9.2M
Net income discontinuous operations
68.57%-2.72M
98.88%-27K
77.70%-430K
66.24%-789K
--0
-80.96%-8.66M
-109.15%-2.4M
-227.33%-1.93M
---2.34M
---181K
Minority interest income
0
0
0
0
97.88%-5K
0
0
75.00%-5K
Net income attributable to the parent company
49.66%-7.04M
-42.45%-4.06M
37.20%-1.61M
28.92%1.06M
74.18%-2.42M
9.07%-13.98M
32.78%-2.85M
10.46%-2.57M
121.79%823K
-109.09%-9.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
49.66%-7.04M
-42.45%-4.06M
37.20%-1.61M
28.92%1.06M
74.18%-2.42M
9.07%-13.98M
32.78%-2.85M
10.46%-2.57M
121.79%823K
-109.09%-9.38M
Basic earnings per share
54.21%-5.17
-51.01%-2.99
37.57%-1.18
27.87%0.78
83.61%-1.78
55.98%-11.29
68.47%-1.98
59.53%-1.89
108.96%0.61
-34.24%-10.86
Diluted earnings per share
54.21%-5.17
-51.01%-2.99
37.57%-1.18
27.87%0.78
83.61%-1.78
55.98%-11.29
68.47%-1.98
59.53%-1.89
108.96%0.61
-34.24%-10.86
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 13.27%5.05M56.50%1.22M18.41%1.54M0.69%1.31M1.87%1.26M-39.96%4.45M4.44%777K-17.32%1.3M-66.38%1.3M-61.74%1.23M
Operating revenue 13.27%5.05M56.50%1.22M18.41%1.54M0.69%1.31M1.87%1.26M-39.96%4.45M4.44%777K-17.32%1.3M-66.38%1.3M-61.74%1.23M
Cost of revenue 36.29%2.96M364.61%827K26.16%1.03M-2.62%633K19.19%820K-64.37%2.17M-80.22%178K-27.48%818K-81.14%650K-80.10%688K
Gross profit -8.68%2.08M-35.06%389K5.21%505K4.02%673K-20.04%435K73.12%2.28M483.97%599K8.60%480K57.42%647K328.57%544K
Operating expense 16.82%9.69M56.21%2.67M20.67%2.27M28.18%2.69M-21.87%3.46M-49.85%8.3M-58.63%1.71M-57.66%1.88M-58.07%2.1M-6.62%4.43M
Selling and administrative expenses 17.09%9.64M56.27%2.66M20.35%2.24M29.36%2.68M-21.67%3.19M-45.24%8.23M-53.18%1.7M-55.43%1.86M-55.42%2.07M-6.39%4.07M
Research and development costs -17.19%53K44.44%13K60.00%24K-62.96%10K-24.23%272K-95.76%64K-98.20%9K-94.12%15K-92.48%27K-9.11%359K
Operating profit -26.49%-7.61M-105.50%-2.28M-25.98%-1.76M-38.93%-2.02M22.13%-3.03M60.48%-6.02M74.12%-1.11M65.00%-1.4M68.39%-1.45M22.00%-3.89M
Net non-operating interest income expense 12.52%782K125.48%354K75.19%233K-27.54%150K-77.27%45K140.48%695K-5.42%157K40.00%133K590.00%207K19,900.00%198K
Non-operating interest income 12.52%782K125.48%354K75.19%233K-27.54%150K-77.27%45K140.48%695K-5.42%157K40.00%133K590.00%207K--198K
Other net income (expense) 125,950.00%2.52M-514.99%-2.1M-44.80%345K-15.51%3.72M110.12%558K-99.95%2K-46.74%507K-61.16%625K469.60%4.4M-1,578.55%-5.52M
Gain on sale of security -414.96%-1.47M-439.72%-1.97M-45.72%330K-109.74%-430K111.55%593K-85.42%468K-56.43%579K-67.66%608K--4.42M---5.14M
Earnings from equity interest ------------------0-------------------430K
Special income (charges) 4,819.05%3.96M--0--0--4M-300.00%-38K-106.88%-84K77.48%-84K--0--0-94.71%19K
-Less:Impairment of capital assets -68.14%36K--0--0--0--36K-62.46%113K--113K--0--0--0
-Gain on sale of property,plant,equipment 13,693.10%4M--0--0--4M-110.53%-2K-90.76%29K140.28%29K--0--0-94.21%19K
Other non- operating income (expenses) 108.12%31K-1,241.67%-137K-11.76%15K1,253.85%150K-90.63%3K-25.25%-382K400.00%12K106.27%17K70.45%-13K128.57%32K
Income before tax 19.02%-4.31M-805.39%-4.03M-84.98%-1.18M-41.38%1.85M73.67%-2.42M50.80%-5.32M85.95%-445K72.06%-639K183.12%3.16M-99.63%-9.2M
Income tax 0.00%8K14.29%8K00-42.86%8K-46.15%7K01K
Net income 49.68%-7.04M-42.45%-4.06M37.20%-1.61M29.71%1.06M74.18%-2.42M10.42%-13.99M34.08%-2.85M10.78%-2.57M121.54%818K-103.56%-9.38M
Net income continuous Operations 18.99%-4.32M-793.14%-4.04M-84.98%-1.18M-41.36%1.85M73.67%-2.42M50.79%-5.33M85.79%-452K72.07%-639K183.09%3.16M-99.63%-9.2M
Net income discontinuous operations 68.57%-2.72M98.88%-27K77.70%-430K66.24%-789K--0-80.96%-8.66M-109.15%-2.4M-227.33%-1.93M---2.34M---181K
Minority interest income 000097.88%-5K0075.00%-5K
Net income attributable to the parent company 49.66%-7.04M-42.45%-4.06M37.20%-1.61M28.92%1.06M74.18%-2.42M9.07%-13.98M32.78%-2.85M10.46%-2.57M121.79%823K-109.09%-9.38M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 49.66%-7.04M-42.45%-4.06M37.20%-1.61M28.92%1.06M74.18%-2.42M9.07%-13.98M32.78%-2.85M10.46%-2.57M121.79%823K-109.09%-9.38M
Basic earnings per share 54.21%-5.17-51.01%-2.9937.57%-1.1827.87%0.7883.61%-1.7855.98%-11.2968.47%-1.9859.53%-1.89108.96%0.61-34.24%-10.86
Diluted earnings per share 54.21%-5.17-51.01%-2.9937.57%-1.1827.87%0.7883.61%-1.7855.98%-11.2968.47%-1.9859.53%-1.89108.96%0.61-34.24%-10.86
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Constellation Brands
STZ
187.495
eBay
EBAY
67.600
Lantheus
LNTH
104.210
4
Halozyme Therapeutics
HALO
60.930
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
3.115
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀